Citius Oncology prices USD9.0m public offering

Genetic Leap's GL-IL2-138 receives FDA IND clearance

Amphix Bio's AMFX-200 receives US FDA Orphan Drug Designation to treat acute spinal cord injury

Innovent Biologics' Phase 1 anti-CLDN18.2 ADC (IBI343) results published in Nature Medicine

Revelation Biosciences reports completion of dosing in Phase 1b PRIME study for chronic kidney disease

Sanofi receives US fast track designation for gene therapy targeting geographic atrophy

Currax expands access to Contrave obesity treatment

Varian launches IntelliBlate in Europe, expanding image-guided microwave ablation for cancer care

Biophytis partners with Lynx Analytics to advance AI-driven drug discovery for sarcopenia

Niagen Bioscience introduces Tru Niagen and Niagen IV at Equinox Hotel New York

Gilead showcases efficacy of twice-yearly lenacapavir for HIV prevention at IAS 2025

GSK announces submission of RSV vaccine Arexvy for FDA review

Imugene announces Azer-cel Phase 1b clinical trial data

FDA approves Merck Animal Health's once-yearly flea and tick treatment for dogs

Scopio Labs secures fourth FDA clearance